
TSE:ZUH
This summary was created by AI, based on 1 opinions in the last 12 months.
The BMO EqWt US HthCare Hedged CAD (ZUH-T) is recognized for its equal-weight approach, which mitigates risk by avoiding over-concentration in mega-pharma companies. Experts highlight the lower volatility of the healthcare sector, making it a strategic choice for diversification amidst the current narrow leadership in market indexes. The healthcare sector is characterized by defensive growth and steady demand, with companies tending to have strong balance sheets and low sensitivity to economic fluctuations. Additionally, there is significant potential for growth driven by innovation, particularly in AI, which could offer substantial benefits to investors. The review emphasizes the positive aspects of holding this exposure through futures markets rather than owning the ETF directly, suggesting a sophisticated investment strategy tailored to client needs.
This has more health care in it, rather than pharmaceuticals. FT AlphaDEX US Health Care (FHH-T) is a rule based ETF in the healthcare area, but they use the Russell 1000, drilling down a little bit more into some of the smaller and less recognizable companies. With this one he is not buying a US health care with an impoverished Cdn$.
US healthcare is one area that hasn’t been on people’s radar for quite a while but has been performing pretty well. Healthcare is typically one or 2 products that really drive the earnings of each company. This is an equal weighted ETF, so regardless of which company does well, as long as the overall sector does well it should do well.
He likes this because it is equal weighted and hedged against the decline in the US$. You can quite comfortably put this into your portfolio.